Streetbeat News

Price Targets

RJF

Morgan Stanley analyst Manan Gosalia has assumed Raymond James Financial (NYSE:RJF) with an Equal-Weight rating and set a price target of $112.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:53 am

MQ

Deutsche Bank analyst Bryan Keane has reiterated a 'Buy' rating on Marqeta (NASDAQ:MQ) and maintained a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 9:52 am

SQM

JP Morgan analyst Samik Chatterjee maintains an Overweight rating on Sociedad Quimica Y Minera (SQM) but lowers the price target from $97 to $93.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 9:50 am

ENVX

TD Cowen analyst Gabe Daoud has downgraded Enovix (NASDAQ:ENVX) from Outperform to Market Perform, while raising the price target from $19 to $20.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:50 am

AZPN

Loop Capital analyst Mark Schappel has downgraded Aspen Technology (NASDAQ:AZPN) from Buy to Hold and lowered the price target from $240 to $170.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:49 am

STNG

B of A Securities analyst Ken Hoexter has downgraded Scorpio Tankers (NYSE:STNG) from Buy to Neutral and lowered the price target from $60 to $45.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:48 am

CCI

BMO Capital analyst Ari Klein has maintained an 'Underperform' rating on Crown Castle (NYSE:CCI) and lowered the price target from C$113 to C$106.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 9:48 am

RXRX

Needham analyst Gil Blum has reiterated a 'Buy' rating on Recursion Pharmaceuticals (NASDAQ:RXRX) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:46 am

WNS

Needham analyst Mayank Tandon has reiterated a 'Buy' rating on WNS (Hldgs) (NYSE:WNS) and maintained a price target of $115.

Portfolio Pulse from richadhand@benzinga.com

July 21, 2023 | 9:46 am

LIFE

Piper Sandler analyst Edward Tenthoff maintains aTyr Pharma (NASDAQ:LIFE) with an Overweight rating and raises the price target from $13 to $20.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 9:44 am